4Bio Capital, a London-based venture capital (VC) firm, is looking to close its third fund in the first half of next year with plans to invest in advanced therapeutic companies in Asia as part of its decade-long strategy, a top executive told DealStreetAsia.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
